CIM vs. ARR, MFA, PMT, RWT, TWO, DX, NYMT, RC, ARI, and ACRE
Should you be buying Chimera Investment stock or one of its competitors? The main competitors of Chimera Investment include ARMOUR Residential REIT (ARR), MFA Financial (MFA), PennyMac Mortgage Investment Trust (PMT), Redwood Trust (RWT), Two Harbors Investment (TWO), Dynex Capital (DX), New York Mortgage Trust (NYMT), Ready Capital (RC), Apollo Commercial Real Estate Finance (ARI), and Ares Commercial Real Estate (ACRE). These companies are all part of the "mortgage reits" industry.
ARMOUR Residential REIT (NYSE:ARR) and Chimera Investment (NYSE:CIM) are both small-cap finance companies, but which is the superior business? We will contrast the two companies based on the strength of their community ranking, dividends, analyst recommendations, institutional ownership, risk, media sentiment, profitability, earnings and valuation.
ARMOUR Residential REIT pays an annual dividend of $2.88 per share and has a dividend yield of 15.6%. Chimera Investment pays an annual dividend of $0.44 per share and has a dividend yield of 10.5%. ARMOUR Residential REIT pays out -400.0% of its earnings in the form of a dividend. Chimera Investment pays out 191.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. ARMOUR Residential REIT is clearly the better dividend stock, given its higher yield and lower payout ratio.
In the previous week, ARMOUR Residential REIT had 12 more articles in the media than Chimera Investment. MarketBeat recorded 16 mentions for ARMOUR Residential REIT and 4 mentions for Chimera Investment. ARMOUR Residential REIT's average media sentiment score of 0.77 beat Chimera Investment's score of 0.42 indicating that Chimera Investment is being referred to more favorably in the news media.
ARMOUR Residential REIT has a beta of 1.48, suggesting that its stock price is 48% more volatile than the S&P 500. Comparatively, Chimera Investment has a beta of 1.68, suggesting that its stock price is 68% more volatile than the S&P 500.
54.2% of ARMOUR Residential REIT shares are owned by institutional investors. Comparatively, 48.4% of Chimera Investment shares are owned by institutional investors. 1.3% of ARMOUR Residential REIT shares are owned by insiders. Comparatively, 0.7% of Chimera Investment shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
ARMOUR Residential REIT currently has a consensus price target of $19.25, indicating a potential upside of 3.94%. Chimera Investment has a consensus price target of $5.50, indicating a potential upside of 31.26%. Given ARMOUR Residential REIT's higher possible upside, analysts clearly believe Chimera Investment is more favorable than ARMOUR Residential REIT.
Chimera Investment has higher revenue and earnings than ARMOUR Residential REIT. ARMOUR Residential REIT is trading at a lower price-to-earnings ratio than Chimera Investment, indicating that it is currently the more affordable of the two stocks.
Chimera Investment has a net margin of 16.32% compared to Chimera Investment's net margin of -3.83%. Chimera Investment's return on equity of 15.63% beat ARMOUR Residential REIT's return on equity.
Chimera Investment received 142 more outperform votes than ARMOUR Residential REIT when rated by MarketBeat users. Likewise, 58.00% of users gave Chimera Investment an outperform vote while only 50.00% of users gave ARMOUR Residential REIT an outperform vote.
Summary
Chimera Investment beats ARMOUR Residential REIT on 11 of the 18 factors compared between the two stocks.
Get Chimera Investment News Delivered to You Automatically
Sign up to receive the latest news and ratings for CIM and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CIM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Chimera Investment Competitors List
Related Companies and Tools
